Storm Boswik| Board Of Directors| Zinc8 Energy Solutions Inc


 

On June 7, 2022, Zinc8 Energy Solutions Inc announced the addition of a new Board of Director Storm Boswik. The Director Storm Boswik has a background in investment and previously worked in senior-level jobs in various organizations. The new board of directors, Storm Boswik, has experience in Portfolio management and consultant in both public & private capital and debt. 


As a new board of directors, Storm Boswik is responsible for good corporate governance, corporate advisory, mergers, acquisitions, public partnerships, private partnerships, company capital formation, and introductions. 

Storm  Boswick has substantial experience in investment, conference presentations, lectures and more. 

“Storm Brings tremendous experience and a deep industry network to Zinc8,” said Ron MacDonald, President and CEO.


Currently, Storm Boswik is the owner and managing director of TRE Advisors. He plays a vital role in the investment communities and the relevant industries. In the past, Mr. Boswick also worked for Goldman Sachs as a researcher, Managing partner at J & W Seligman, Managing director at Brock Capital and founder of Brompton Cross. 


On June 7, 2022, the company announced the resignation of Sean Charland from its board of directors. 


About Energy Solutions Inc Zin8 is developing a cost-effective alternative source of energy Zinc-air battery. 


The ZAIRF is the Zinc8 Enertgy Solutions Inc ticker and the ZAIRF stock is traded on the OTC Exchange. The price of  ZAIRF Stock was 0.15 US dollars on July 14, 2022.
Location: United States

Comments

Post a Comment

Popular posts from this blog

Trillium Gold Mines Inc- Overview

Image
TGLDF- Trillium Gold Mines Inc head office is based in Canada. The main activity of this company is to find new mineral assets on the earth. Currently, the company is working on gold exploration in the Red Lake. The company is involved in several projects, some of them are Newman Todd, Red Lake West, Shining Tree, copper lode west etc.  Trillium Gold Mines Inc-  TGLDF  is showing consistent growth in revenues for the last few years. The company started its operations on November 3, 2005, the company's head office is in Vancouver.  The current share price on 27 May 2022 is 0.31 (Canadian dollars).  On 8th March 2022, the company offered 1,25,0000  incentive stock to Its management ( include of directors and other employees). The offer also includes the option to buy a common share by its management.  On March 2, 2022. Trillium Gold Mines Inc announced the closing of c$7.5million brokered private placement. On April 26, 2022. Trillium Gold Mines
Read more

LGIQ Busienss Overview

Image
LGIQ Busienss Overview LGIQ started its operations on 4 November 2022 and the company head office is in NewYork, United States. The company is involved in digital marketing and lead generation solutions for its customers.  The company business has two-part: one is digital marketing and the other is consumer marketplace. The company provides e-commerce solutions to Europe, Asia and America. The company data management tools and funnels help you find the right business consumers. The company's target customers are small and medium-sized businesses.  Brent Suen is the Chief Executive Officer and the John MacNeil is the Chief Operating Officer. Approximately more than 37 employees are working in LOGIQ.  LGIQ Stock LGIQ Stock is currently (13 June 2022) selling at 0.39 US Dollars. For the last five years, the stock price has been showing a decrease in the price. The stock was trading at 88.54 US dollars on 2 January 2018, and after this, the stock price for company shares is consistent
Read more

Interpace Biosciences Completes Its Pharma Services Business Sale to Flagship Biosciences, Inc.

Image
The Company announces the complete sale of the pharma services business which could impact the IDXG Stock . For more information regarding the Company's business, visit OTC Wiki.  Interpace Biosciences Inc is a leading company that specializes in enabling personalized medicinal products. This Company has closed a definitive asset purchase agreement under the Flagship of Biosciences Inc. It has acquired the Company's pharma services business.  The Company will also use the proceeds from the transaction for working capital requirements and investments to help drive the growth of its molecular diagnostics business. The president and CEO of the Company also announced that with the completion of the multiple transactions, we expect the Company to make progress. Moreover, the company's driven ash flow will focus on molecular diagnostics that the Company is offering the best in class solutions and other diagnostic insights. Besides providing the IDXG Stock, the Company determines
Read more